within Pharmacolibrary.Drugs.ATC.N;

model N06AX26
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.75,
    Cl             = 33 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,
    adminCount     = 1,
    Vd             = 2.6,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0021666666666666666,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Vortioxetine is an antidepressant approved for the treatment of major depressive disorder (MDD) in adults. It acts as a serotonin modulator and stimulator, functioning as a serotonin reuptake inhibitor and agonist or antagonist at various serotonin receptors. It is currently approved and in use for the treatment of depression in many countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters as reported in healthy adult volunteers after single and multiple oral doses of vortioxetine.</p><h4>References</h4><ol><li><p>Chen, G, et al., &amp; Nomikos, G (2018). Vortioxetine: Clinical Pharmacokinetics and Drug Interactions. <i>Clinical pharmacokinetics</i> 57(6) 673–686. DOI:<a href=&quot;https://doi.org/10.1007/s40262-017-0612-7&quot;>10.1007/s40262-017-0612-7</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29189941/&quot;>https://pubmed.ncbi.nlm.nih.gov/29189941</a></p></li><li><p>Fagiolini, A, et al., &amp; Christensen, MC (2024). Clinical benefits and bioequivalence of vortioxetine oral drop solution versus oral tablets. <i>Journal of psychopharmacology (Oxford, England)</i> 38(2) 156–161. DOI:<a href=&quot;https://doi.org/10.1177/02698811231216320&quot;>10.1177/02698811231216320</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38126222/&quot;>https://pubmed.ncbi.nlm.nih.gov/38126222</a></p></li><li><p>Garnock-Jones, KP (2014). Vortioxetine: a review of its use in major depressive disorder. <i>CNS drugs</i> 28(9) 855–874. DOI:<a href=&quot;https://doi.org/10.1007/s40263-014-0195-x&quot;>10.1007/s40263-014-0195-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25145538/&quot;>https://pubmed.ncbi.nlm.nih.gov/25145538</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N06AX26;
